Turmeric and Green Tea: A Recipe for the Treatment of B-Chronic Lymphocytic Leukemia

被引：22

作者：

Angelo, Laura S. ^{[1
]}

Kurzrock, Razelle ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Div Canc Med, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA

来源：

CLINICAL CANCER RESEARCH | 2009年 / 15卷 / 04期

关键词：

LIPOSOME-ENCAPSULATED CURCUMIN; FACTOR-KAPPA-B; IN-VITRO; APOPTOSIS; CANCER; PROLIFERATION; ANGIOGENESIS; CELLS; SUPPRESSION; PATHWAY;

D O I：

10.1158/1078-0432.CCR-08-2791

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Two naturally occurring compounds, curcumin, the active ingredient in the spice turmeric, and the green tea extract epigallocatechin-3-gallate, have marked effects on the apoptotic machinery in chronic lymphocytic leukemia. These results provide a preclinical foundation for future clinical use of these compounds in this disease.

引用

页码：1123 / 1125

页数：3

共 13 条

[1] Phase II trial of curcumin in patients with advanced pancreatic cancer [J].

Dhillon, Navneet ;

Aggarwal, Bharat B. ;

Newman, Robert A. ;

Wolff, Robert A. ;

Kunnumakkara, Ajaikumar B. ;

Abbruzzese, James L. ;

Ng, Chaan S. ;

Badmaev, Vladimir ;

Kurzrock, Razelle .

CLINICAL CANCER RESEARCH, 2008, 14 (14) :4491-4499

[2] Preclinical assessment of curcumin as a potential therapy for B-CLL [J].

Everett, Peter C. ;

Meyers, John A. ;

Makkinje, Anthony ;

Rabbi, Mohammed ;

Lerner, Adam .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) :23-30

[3] Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG [J].

Ghosh, Asish K. ;

Kay, Neil E. ;

Secreto, Charla R. ;

Shanafelt, Tait D. .

CLINICAL CANCER RESEARCH, 2009, 15 (04) :1250-1258

[4]

Gonzales Gustavo F., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P429, DOI 10.2174/187152006778226486

[5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[6] Curcumin: From ancient medicine to current clinical trials [J].

Hatcher, H. ;

Planalp, R. ;

Cho, J. ;

Tortia, F. M. ;

Torti, S. V. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (11) :1631-1652

[7] Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins [J].

Kunnumakkara, Ajaikumar B. ;

Anand, Preetha ;

Aggarwal, Bharat B. .

CANCER LETTERS, 2008, 269 (02) :199-225

[8] Liposome-encapsulated curcumin - In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis [J].

Li, L ;

Braiteh, FS ;

Kurzrock, R .

CANCER, 2005, 104 (06) :1322-1331

[9] Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis [J].

Li, L ;

Aggarwal, BB ;

Shishodia, S ;

Abbruzzese, J ;

Kurzrock, R .

CANCER, 2004, 101 (10) :2351-2362

[10] Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer [J].

Li, Lan ;

Ahmed, Bilal ;

Mehta, Kapil ;

Kurzrock, Razelle .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) :1276-1282

← 1 2 →